Clinical Research Directory
Browse clinical research sites, groups, and studies.
COVID-19: A POC Test Under Research & Evaluation
Sponsor: LumiraDx UK Limited
Summary
Collection of nasal/nasopharyngeal/throat swabs and blood samples from patients presenting at their designated care facility displaying symptoms of COVID-19 and undergoing a SOC SARS-CoV-2 test or those who have tested positive in the past to aid development, calibration and performance evaluation for the LumiraDx POC test.
Official title: Specimen Collection for Development and Performance Evaluation of the LumiraDx Platform Point of Care Tests for Sars-Cov-2 IgG/IgM & Antigen to be Used as an Aid in Diagnosis of COVID-19
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
523
Start Date
2020-05-01
Completion Date
2020-05-26
Last Updated
2026-06-15
Healthy Volunteers
No
Conditions
Interventions
Sample Collection/Performance Evaluation (A)
This is a prospective sample collection and performance evaluation study which involves no therapeutic intervention. Sample types include: * Nasal/Throat/Nasal Throat Combo/ Nasopharyngeal (as per sites SOC) Swab * Whole Venous Blood
Sample Collection/Performance Evaluation (B)
This is a prospective sample collection and performance evaluation study which involves no therapeutic intervention. Sample types include: * Whole Venous Blood * Fingerstick Capillary Sample
Locations (3)
Barts Health NHS Trust
London, United Kingdom
Homerton University Hospital NHS Foundation Trust
London, United Kingdom
University College London Hospitals NHS Foundation Trust
London, United Kingdom